Skip to main content
Fig. 2 | Orphanet Journal of Rare Diseases

Fig. 2

From: C4OH is a potential newborn screening marker—a multicenter retrospective study of patients with beta-ketothiolase deficiency in China

Fig. 2

The distribution and sample size of the study population at each province/municipality in China. HLJ, Heilongjiang; JL, Jilin; LN, Liaoning; XJ, Xinjiang; IM, Inner Mongolia; BJ, Beijing; TJ, Tianjin, HEB, Hebei; SX, Shanxi; SAX, Shaanxi; NX, Ningxia; GS, Gansu; QH, Qinghai; SD, Shandong; JS, Jiangsu; AH, Anhui; HEN, Henan; SH, Shanghai; HUB, Hubei; CQ, Chongqing; SC, Sichuan; ZJ, Zhejiang; JX, Jiangxi; HUN, Hunan; GZ, Guizhou; YN, Yunnan; FJ, Fujian; TW, Taiwan; GD, Guangdong; GX, Guangxi; HN, Hainan, HK, Hongkong; MC, Macau. Gray areas indicate that no screening data were included. The darker the color, the larger the sample size. Blue circles represent the detection of positive BKTD cases with genetic confirmation

Back to article page